Find a Clinical Trial
Right for You
Browse our currently enrolling studies across a wide range of medical specialties. Participation is voluntary and open to eligible individuals.
RENEW-HF: Cardiovascular Risk Reduction in High-Risk Adults
Cardiovascular Disease / Heart Failure
A randomized, double-blind study evaluating a novel oral therapy for reducing cardiovascular events in adults with established heart failure and reduced ejection fraction.
- ·Ages 40–80
- ·Diagnosed with heart failure (EF < 40%)
- ·No recent hospitalization within 30 days
CLEAR-SKIN: Biologic Therapy for Moderate-to-Severe Plaque Psoriasis
Dermatology / Psoriasis
An open-label extension study assessing the long-term safety and efficacy of a subcutaneous biologic agent for adults with moderate-to-severe plaque psoriasis.
- ·Ages 18–65
- ·Plaque psoriasis affecting ≥10% BSA
- ·Inadequate response to topical therapy
METRO-T2D: Metformin Optimization in Type 2 Diabetes Management
Endocrinology / Type 2 Diabetes
A post-marketing surveillance study examining the real-world effectiveness and safety of an optimized metformin formulation in diverse adult populations with Type 2 Diabetes.
- ·Ages 30–70
- ·Diagnosed with Type 2 Diabetes for ≥1 year
- ·HbA1c between 7.5% and 11%
ALLERGY-SHIELD: Sublingual Immunotherapy for Seasonal Allergic Rhinitis
Allergy / Immunology
A multi-center, placebo-controlled trial evaluating the efficacy of sublingual allergen immunotherapy tablets in reducing seasonal allergy symptoms in adults and adolescents.
- ·Ages 12–60
- ·Documented seasonal allergic rhinitis
- ·Positive skin prick test to grass or tree pollen
GUT-RESTORE: Microbiome Modulation in Crohn's Disease
Gastroenterology / Crohn's Disease
A pilot study investigating the safety and preliminary efficacy of a probiotic consortium in achieving and maintaining clinical remission in adults with mild-to-moderate Crohn's disease.
- ·Ages 18–55
- ·Confirmed Crohn's disease diagnosis
- ·Harvey-Bradshaw Index score 5–16
PEDS-ASTHMA: Inhaled Corticosteroid Step-Down in Pediatric Asthma
Pediatrics / Asthma
A randomized controlled trial assessing the safety of a guided step-down approach to inhaled corticosteroid therapy in children with well-controlled persistent asthma.
- ·Ages 6–17
- ·Persistent asthma, well-controlled for ≥3 months
- ·Currently on low-to-medium dose ICS
Don't See the Right Trial?
New studies open regularly. Sign up to be notified when trials matching your health condition become available.
Get Notified